Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 12Triple Negative Breast Neoplasms 2Neoplasms 1Lymphedema 1Breast Cancer Invasive 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pycnogenols 2Pentoxifylline 2pirfenidone 1pazopanib 1Vitamin E 1Tocopherols 1Technetium Tc 99m Sulfur Colloid 1Surgical Procedures, Operative 1Standard of Care 1Sodium Selenite 1Sodium Chloride 1Sentinel Lymph Node Biopsy 1Radiotherapy 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Methylene Blue 1Mastectomy, Segmental 1Mastectomy 1Manual Lymphatic Drainage 1Lymph Node Excision 1Lipectomy 1Ketoprofen 1Indocyanine Green 1Hyperbaric Oxygenation 1Drug Therapy 1Compression Bandages 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphedema × Mastectomy × Clear all
NCT06092892 2026-05-11

IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases

Cedars-Sinai Medical Center

Phase 2 Recruiting
45 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡